Can an intravenous iron infusion be given at 35 weeks gestation?

Yes, intravenous iron infusion can be safely given at 35 weeks gestation

Intravenous iron is safe and effective for treating iron deficiency anemia at 35 weeks gestation, with all modern IV iron formulations demonstrating safety in pregnancy after the first trimester. 1

Key Safety and Efficacy Points

The 2024 expert consensus guidelines explicitly state that "Administration of IV iron is generally avoided prior to the 13th week of gestation due to a lack of safety data. There is no difference in the administration of IV iron compared with the non-pregnant person, and all IV iron formulations above have been shown to be safe and effective in pregnancy." 1 At 35 weeks, you are well beyond this safety threshold.

Important Clinical Considerations at 35 Weeks:

Timing matters for optimal outcomes:

• While IV iron can be given at 35 weeks, earlier administration (before 34 weeks) produces superior hemoglobin responses 2
• A study of 295 pregnant patients showed mean hemoglobin improvement of 2.5 g/dL when IV iron was given <34 weeks versus only 1.3 g/dL at ≥34 weeks (p<0.001) 2
• Optimal benefit requires ≥6 weeks latency between infusion and delivery with doses ≥800 mg (hemoglobin increase of 2.6-3.1 g/dL) 2

At 35 weeks specifically:

• You have approximately 3-5 weeks until delivery, which is suboptimal but still beneficial
• Hemoglobin typically increases within 1-2 weeks, with 1-2 g/dL rise by 4-8 weeks 1
• Studies in patients at 32-35 weeks showed mean hemoglobin rise of 2.0 g/dL by day 28 3

Formulation Selection

Preferred formulations at 35 weeks:

• Ferric derisomaltose (FDI) or ferric carboxymaltose (FCM) allow single high-dose infusions (up to 1000 mg), which is advantageous given limited time before delivery 1
• Iron sucrose requires multiple smaller doses (200 mg) on alternate days, which may be logistically challenging this late in pregnancy 3

Critical Safety Protocols

No fetal monitoring is required:

• The guidelines explicitly state: "Fetal monitoring during or following IV iron administration is not required and the authors recommend against it" 1

Watch for potential contraction effect:

• One study of 136 pregnant women beyond 35 weeks receiving IV iron found 72.1% developed temporary regular contractions on post-treatment NST 4
• This effect may lead to earlier delivery in women with prior cesarean section (mean delivery at 36.82 weeks vs 38.48 weeks overall) 4
• These are typically temporary and self-limited, but warrant awareness

Standard infusion precautions apply:

• Start infusion slowly and observe for several minutes for complement activation-related pseudo-allergy (CARPA) 1
• Most reactions are non-IgE mediated, self-limited, and characterized by flushing, myalgias, back pain, or chest pressure 1
• True anaphylaxis is extremely rare

Practical Administration

Dosing approach at 35 weeks:

• Calculate total iron deficit
• Administer maximum feasible dose given time constraints (up to 1000 mg for FCM/FDI) 1
• If using iron sucrose, give 200 mg doses on alternate days 3

Expected outcomes:

• Patients receiving IV iron >10 days before delivery have significantly higher hemoglobin at delivery (11.1 vs 9.7 g/dL), fewer blood transfusions, and reduced preterm births compared to those receiving it <10 days before delivery 5

Common Pitfalls to Avoid

• Don't delay treatment thinking it's "too late" - even at 35 weeks, IV iron reduces transfusion risk and improves maternal outcomes 5, 6
• Don't order fetal monitoring - this is unnecessary and not recommended 1
• Don't use generic ferumoxytol - it has double the infusion reaction rate of brand formulation with a reported death 1
• Don't check iron parameters within 4 weeks of infusion as circulating iron interferes with assays 1

The evidence strongly supports IV iron administration at 35 weeks gestation as both safe and beneficial, though earlier treatment would have been preferable for maximal hemoglobin response.